News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
Roche intends to acquire all outstanding shares of Genentech for US$95.00 per share in cash
13-Mar-2009 - Roche and Genentech announced that they signed a merger agreement under which Roche will acquire the outstanding publicly held interest in Genentech for US$95.00 per share in cash, or a total payment of approximately US$46.8 billion to equity holders of Genentech other than Roche. The special ...
06-Mar-2009 - Tecan and GE Healthcare are working together to bring increased quality and efficiency to process development. The collaboration between the two suppliers focuses on high throughput screening of protein purification conditions, using the combination of Tecan’s Freedom EVO® automated workstation ...
28-Jan-2009 - Neurotune AG announced a change in the management. Starting March 1st 2009, Dr. Bruno Oesch will take over the position of Chief Executive Officer from Dr. Andreas J. Schulze, who joined Neurotune in 2005 and is holding the position of CEO since 2006. Andreas J. Schulze will leave at his request ...
Key appointments of Chief Financial Officer and Chief Medical Director
28-Jan-2009 - AC Immune SA announced that it has successfully completed its financing round C by raising CHF 40 million from existing investors and it has made two key appointments of Chief Financial Officer and Chief Medical Director. These developments build on the progress in its clinical pipeline ...
02-Dec-2008 - Zealand Pharma A/S and Helsinn Healthcare SA announced that it has signed a partnering agreement, for the development and worldwide commercialization of ZP1846, a GLP-2 (glucagon-like peptide-2) receptor agonist which provides a novel way to treat chemotherapy-induced diarrhea (CID), a ...
Financing from Swiss investors begins long-term nanoparticle drug development programme
19-Nov-2008 - Midatech Group announced the formation of a Basel-based Swiss drug development subsidiary, PharMida AG. Formation of this subsidiary follows an investment by a group of Switzerland-based private investors into Midatech Ltd. The mandate of PharMida is to develop a strong portfolio of clinically ...
Five Research Teams Selected to Receive Funding for Preclinical and
16-Oct-2008 - The Michael J. Fox Foundation for Parkinson's Research (MJFF) awarded a total of$2 million to five research teams to speed development of effective therapies for the under-addressed cognitive and mood-related symptoms of Parkinson's disease (PD). The award was made possible by leadership funding ...
20-Aug-2008 - PregLem SA announced the start of an international Phase III clinical trial program for PGL4001 (ulipristal) in symptomatic uterine myoma, a common benign solid tumor of the genital tract in women of reproductive age. PGL4001, an orally active, selective progesterone receptor modulator, was shown ...
© 1997-2024 LUMITOS AG, All rights reserved